CME/CE

Use the tool below to view all available Eye Health Academy Series

The Dry Eye Diet: Evaluating the Nutraceutical Evidence
The Dry Eye Diet: Evaluating the Nutraceutical Evidence
Live Broadcast
The Dry Eye Diet: Evaluating the Nutraceutical Evidence
Synchronous Virtual Program
07:00 PM - 08:00 PM ET
1.00 credit Learn more
New Strategies for Individualizing Treatment in DME
New Strategies for Individualizing Treatment in DME
CME/CE
New Strategies for Individualizing Treatment in DME
0.25 credits
- Luis A. Gonzalez, MD, MPH
- Jeremiah Brown Jr., MD, MS, FASRS
0.25 credits
Understanding Antibody-Drug Conjugates (ADCs)
Understanding Antibody-Drug Conjugates (ADCs)
CME/CE
Understanding Antibody-Drug Conjugates (ADCs)
0.25 credits
- Aaron Samuel Gold, OD, FAAO
- Carlo J. Pelino, OD, FAAO
0.25 credits
Collaborative Care: Managing ADC-Related Ocular Toxicities
Collaborative Care: Managing ADC-Related Ocular Toxicities
CME/CE
Collaborative Care: Managing ADC-Related Ocular Toxicities
0.25 credits
- Kathleen N. Moore, MD, MS, FASCO
- Carlo J. Pelino, OD, FAAO
0.25 credits
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
CME/CE
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
0.25 credits
- Kathleen N. Moore, MD, MS, FASCO
- Kamran M. Riaz, MD
0.25 credits
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
CME/CE
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
0.25 credits
- Aaron Samuel Gold, OD, FAAO
- Timothy G. Murray, MD, MBA, FASRS
0.25 credits
MinuteCE®
What’s New in Glaucoma Therapy?
1.00 credit 10 episodes
- Paul Petrakos, DO, MS
- Justin Schweitzer, OD, FAAO
- I. Paul Singh, MD
- Sarah H. Van Tassel, MD
1.00 credit 10 episodes
3D Heads-Up Visualization: Cases in Glaucoma Surgery
3D Heads-Up Visualization: Cases in Glaucoma Surgery
MinuteCE®
3D Heads-Up Visualization: Cases in Glaucoma Surgery
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
New Solutions for Optimizing IOP Control: A Case-Based Approach
New Solutions for Optimizing IOP Control: A Case-Based Approach
MinuteCE®
New Solutions for Optimizing IOP Control: A Case-Based Approach
1.00 program credit
- Sarah H. Van Tassel, MD
- Justin Schweitzer, OD, FAAO
1.00 program credit
What’s New in Schlemm’s Canal MIGS?
What’s New in Schlemm’s Canal MIGS?
MinuteCE®
What’s New in Schlemm’s Canal MIGS?
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
Effective MIGS for Optimal IOP Control: A Case-Based Approach
Effective MIGS for Optimal IOP Control: A Case-Based Approach
MinuteCE®
Effective MIGS for Optimal IOP Control: A Case-Based Approach
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
What’s New in Suprachoroidal MIGS?
What’s New in Suprachoroidal MIGS?
MinuteCE®
What’s New in Suprachoroidal MIGS?
1.00 program credit
- I. Paul Singh, MD
- Paul Petrakos, DO, MS
1.00 program credit
What’s New With 3D Visualization in Glaucoma Surgery?
What’s New With 3D Visualization in Glaucoma Surgery?
MinuteCE®
What’s New With 3D Visualization in Glaucoma Surgery?
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
MinuteCE®
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
Advances in Therapy for Neovascular AMD and Diabetic Eye Disease
Advances in Therapy for Neovascular AMD and Diabetic Eye Disease
CME/CE
Advances in Therapy for Neovascular AMD and Diabetic Eye Disease
0.25 credits
- Veeral Sheth, MD, MBA, FASRS, FACS
- Carl D. Regillo, MD
0.25 credits
Understanding the Anti-VEGF Treatment Burden
Understanding the Anti-VEGF Treatment Burden
CME/CE
Understanding the Anti-VEGF Treatment Burden
0.25 credits
- Veeral Sheth, MD, MBA, FASRS, FACS
- Carl J. Danzig, MD
0.25 credits

CME/CE

Popular

Title

Share on ReachMD